MDL Isentris Platform Selected by LEO Pharma

News   Dec 22, 2005

 
MDL Isentris Platform Selected by LEO Pharma
 
 
 

RELATED ARTICLES

Key Ingredient in Diabetes Drug Modified to Improve Side Effects

News

Improved medications for Type 2 diabetes are one step closer thanks to a new discovery reported this week. By modifying the key ingredient in current diabetes drugs, the researchers produced a compound that was effective for hyperglycemia in animal trials, yet without the most problematic side effects of current drugs.

READ MORE

Tackling Cancer at Ground Zero: Designer Molecule Inhibits Protein Target

News

A new molecule designed by University of Adelaide researchers shows great promise for future treatment of many cancers. The new molecule successfully targets a protein that plays a major role in the growth of most cancers.

READ MORE

Novel ALS Therapy in Human Clinical Trials

News

A phase one/two clinical trial has launched to investigate whether a drug could benefit people with ALS whose disease is caused by mutations in a gene called SOD1

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE
 

We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy